| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1040083675 |
| P356 | DOI | 10.1007/S11010-013-1759-7 |
| P953 | full work available at URL | http://link.springer.com/article/10.1007/s11010-013-1759-7/fulltext.html |
| http://link.springer.com/content/pdf/10.1007/s11010-013-1759-7 | ||
| http://link.springer.com/content/pdf/10.1007/s11010-013-1759-7.pdf | ||
| P698 | PubMed publication ID | 23912396 |
| P5875 | ResearchGate publication ID | 255177105 |
| P50 | author | Bhupesh Singla | Q57334377 |
| P2093 | author name string | Ajay Duseja | |
| Nitin Saini | |||
| Radhika Srinivasan | |||
| Naveen Kalra | |||
| Bal Krishan Sharma | |||
| Shweta Kapil | |||
| Radha Krishan Dhiman | |||
| Yogesh Kumar Chawla | |||
| Anuradha Chakraborti | |||
| P2860 | cites work | Endostatin: an endogenous inhibitor of angiogenesis and tumor growth | Q24315369 |
| Chinese Journal of Oncology | Q27710719 | ||
| High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma | Q84568325 | ||
| Tie2 Receptor Ligands, Angiopoietin-1 and Angiopoietin-2, Modulate VEGF-Induced Postnatal Neovascularization | Q28280017 | ||
| Vascular endothelial growth factor is a secreted angiogenic mitogen | Q28646475 | ||
| Hepatocellular carcinoma | Q29615841 | ||
| Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma | Q29615947 | ||
| Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver | Q29616866 | ||
| Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery | Q30932207 | ||
| Human angiostatin inhibits murine hemangioendothelioma tumor growth in vivo | Q33501025 | ||
| Collagen XVIII/endostatin structure and functional role in angiogenesis | Q33961365 | ||
| V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials | Q34733478 | ||
| Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival | Q35011429 | ||
| Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis | Q35788316 | ||
| Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level | Q36065624 | ||
| Recent evidence in the treatment of small hepatocellular carcinoma. | Q37270682 | ||
| High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies | Q40227356 | ||
| Plasminogen fragment K1-5 improves survival in a murine hepatocellular carcinoma model. | Q40261225 | ||
| Increased endostatin/collagen XVIII expression correlates with elevated VEGF level and poor prognosis in hepatocellular carcinoma. | Q40479708 | ||
| Suppression of Tumor Growth with Recombinant Murine Angiostatin | Q42061946 | ||
| Clinical utility of prothrombin induced by vitamin K absence in the detection of hepatocellular carcinoma in Indian population | Q42278956 | ||
| Urinary angiostatin levels are elevated in patients with epithelial ovarian cancer | Q43195485 | ||
| Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma. | Q43530331 | ||
| Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma | Q44369910 | ||
| Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery | Q44926653 | ||
| Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma | Q44941976 | ||
| Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study | Q45128211 | ||
| The expression of hypoxia-inducible factor-1alpha in hepatitis B virus-related hepatocellular carcinoma: correlation with patients' prognosis and hepatitis B virus X protein | Q45395208 | ||
| Endostatin down-regulates soluble guanylate cyclase (sGC) in endothelial cells in vivo: influence of endostatin on vascular endothelial growth factor (VEGF) signaling | Q46892746 | ||
| High serum levels of vascular endothelial growth factor predict poor response to transarterial chemoembolization in hepatocellular carcinoma: a prospective study. | Q47802947 | ||
| Local imbalance of proangiogenic and antiangiogenic factors: a potential mechanism of focal necrosis and dormancy in tumors. | Q52080711 | ||
| Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy. | Q53172824 | ||
| Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma. | Q54669173 | ||
| Angiopoietin-2 Serum Levels Are Elevated in Patients With Liver Cirrhosis and Hepatocellular Carcinoma | Q58099091 | ||
| Angiostatin induces and sustains dormancy of human primary tumors in mice | Q71101907 | ||
| A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer | Q73221215 | ||
| Quantitation of sinusoid-like vessels in hepatocellular carcinoma: Its clinical and prognostic significance | Q73857025 | ||
| Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo | Q73863756 | ||
| Serum endostatin levels in patients with hepatocellular carcinoma | Q74170706 | ||
| Expression of human macrophage metalloelastase gene in hepatocellular carcinoma: Correlation with angiostatin generation and its clinical significance | Q77355564 | ||
| [Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma] | Q77545082 | ||
| Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndrome | Q77560781 | ||
| Serum endostatin predicts tumor vascularity in hepatocellular carcinoma | Q78462843 | ||
| Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma | Q80581929 | ||
| Enhanced detection of hepatocellular carcinoma | Q81419847 | ||
| Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha | Q83184792 | ||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | angiogenesis inhibitor | Q574834 |
| P304 | page(s) | 103-112 | |
| P577 | publication date | 2013-08-04 | |
| P1433 | published in | Molecular and Cellular Biochemistry | Q1573176 |
| P1476 | title | Serum levels of angiogenic and anti-angiogenic factors: their prognostic relevance in locally advanced hepatocellular carcinoma | |
| P478 | volume | 383 |
| Q27006707 | Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives |
| Q61454351 | Clinical and prognostic significance of circulating levels of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma |
| Q34265632 | Clinical significance of serum and tumor tissue endostatin evaluation in operable non-small cell lung cancer |
| Q38210749 | Matricryptins and matrikines: biologically active fragments of the extracellular matrix |
| Q35610736 | Repeated-measures implication of hepatocellular carcinoma biomarkers in living donor liver transplantation |
| Q55040630 | Serum Endostatin Levels in Oral Squamous Cell Carcinoma. |
Search more.